In recent trading session, Pfizer Inc (NYSE:PFE) saw 22.07 million shares changing hands at last check today with its beta currently measuring 0.64. Company’s recent per share price level of $26.79 trading at -$0.67 or -2.44% at last check today assigns it a market valuation of $151.82B. That most recent trading price of PFE’s stock is at a discount of -17.73% from its 52-week high price of $31.54 and is indicating a premium of 5.94% from its 52-week low price of $25.20. Taking a look at company’s average trading volume for last 10-days demonstrates a volume of 49.79 million shares which gives us an average trading volume of 31.76 million if we extend that period to 3-months.
For Pfizer Inc (PFE), analysts’ consensus is at an average recommendation of Buy while assigning it a mean rating of 2.23. Splitting up the data highlights that, out of 16 analysts covering the stock, 1 rated the stock as a Sell while 1 recommended an Overweight rating for the stock. 7 suggested the stock as a Hold whereas 7 see the stock as a Buy. 0 analyst(s) advised it as an Underweight. The company is expected to be making an EPS of 0.48 in the current quarter.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Pfizer Inc (NYSE:PFE) trade information
Upright in the red during last session for losing -2.44%, in the last five days PFE remained trading in the red while hitting it’s week-highest on Monday, 11/04/24 when the stock touched $26.79 price level, adding 4.8% to its value on the day. Pfizer Inc’s shares saw a change of -6.95% in year-to-date performance and have moved -4.63% in past 5-day. Pfizer Inc (NYSE:PFE) showed a performance of -8.69% in past 30-days. Number of shares sold short was 70.94 million shares which calculate 2.32 days to cover the short interests.
Wall Street analysts have assigned a consensus price target of 46 to the stock, which implies a rise of 41.76% to its recent value today. Analysts have been projecting 20 as a low price target for the stock while placing it at a high target of 70. It follows that stock’s current price would jump 25.35% in reaching the projected high whereas dropping to the targeted low would mean a gain of 25.35% for stock’s current value.
Pfizer Inc (PFE) estimates and forecasts
Statistics highlight that Pfizer Inc is scoring comparatively higher than the scores of other players of the relevant industry. The company lost -4.35% of value to its shares in past 6 months, showing an annual growth rate of 56.52% while that of industry is 7.60. Apart from that, the company came raising its revenue forecast for fiscal year 2024. This year revenue growth is estimated to rise 7.70% from the last financial year’s standing.
12 industry analysts have given their estimates about the company’s current quarter revenue by setting an average figure of 17.35B for the same. And 1 analysts are in estimates of company making revenue of 14.24B in the next quarter. Company posted 14.25B and 14.01B of sales in current and next quarters respectively a year earlier.
Weighing up company’s earnings over the past 5-year and in the next 5-year periods, we find the company posting an annual earnings growth rate of -27.43% during past 5 years. In 2024, company’s earnings growth rate is likely to be around 57.17% while estimates for its earnings growth in next 5 years are of 5.10%.
PFE Dividends
Pfizer Inc is more likely to be releasing its next quarterly report on 2025-Jan-28 and investors are confident in the company announcing better current-quarter dividends despite the fact that it has been facing issues arising out of mounting debt. With an annual yield of 6.23%, the share has a forward dividend of 1.67 which implies that company’s dividend yield remained growing in trailing twelve months while having a 5 year average dividend yield of 4.23%.
Pfizer Inc (NYSE:PFE)’s Major holders
Insiders are in possession of 0.05% of company’s total shares while institution are holding 67.62 percent of that, with stock having share float percentage of 67.65%. Investors also watch the number of corporate investors in a company very closely, which is 67.62% institutions for Pfizer Inc that are currently holding shares of the company. VANGUARD GROUP INC is the top institutional holder at PFE for having 511.4 million shares of worth $14.31 billion. And as of 2024-06-30, it was holding 9.0402 of the company’s outstanding shares.
The second largest institutional holder is BLACKROCK INC., which was holding about 424.38 million shares on 2024-06-30. The number of shares represents firm’s hold over 7.5018 of outstanding shares, having a total worth of $11.87 billion.
